ZA906127B - Azabicyclic compounds - Google Patents

Azabicyclic compounds

Info

Publication number
ZA906127B
ZA906127B ZA906127A ZA906127A ZA906127B ZA 906127 B ZA906127 B ZA 906127B ZA 906127 A ZA906127 A ZA 906127A ZA 906127 A ZA906127 A ZA 906127A ZA 906127 B ZA906127 B ZA 906127B
Authority
ZA
South Africa
Prior art keywords
nitrogen
group
sulphur
chem
oxygen
Prior art date
Application number
ZA906127A
Other languages
English (en)
Inventor
Harry John Wadsworth
John Wadsworth Harry
Steven Dabbs
Dabbs Steven
Paul Adrian Wyman
Adrian Wyman Paul
Sarah Margaret Jenkins
Margaret Jenkins Sarah
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA906127B publication Critical patent/ZA906127B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA906127A 1989-08-05 1990-08-03 Azabicyclic compounds ZA906127B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917957A GB8917957D0 (en) 1989-08-05 1989-08-05 Novel compounds

Publications (1)

Publication Number Publication Date
ZA906127B true ZA906127B (en) 1991-06-26

Family

ID=10661237

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906127A ZA906127B (en) 1989-08-05 1990-08-03 Azabicyclic compounds

Country Status (12)

Country Link
US (1) US5470859A (de)
EP (1) EP0414394B1 (de)
JP (1) JP2958655B2 (de)
KR (1) KR910004616A (de)
AT (1) ATE124697T1 (de)
AU (1) AU629668B2 (de)
CA (1) CA2022633A1 (de)
DE (1) DE69020661T2 (de)
GB (1) GB8917957D0 (de)
IE (1) IE902818A1 (de)
PT (1) PT94910A (de)
ZA (1) ZA906127B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2782792A (en) * 1991-10-15 1993-05-21 Warner-Lambert Company Azabicyclo oxime and amine cholinergic agents and methods of treatment
JPH06239861A (ja) * 1993-02-17 1994-08-30 Kanegafuchi Chem Ind Co Ltd 二環式含チッ素化合物
US6281232B1 (en) * 1993-08-19 2001-08-28 Novo Nordisk A/S Method of treating gastrointestinal motility disorders
JPH11500113A (ja) * 1995-02-17 1999-01-06 ノボ ノルディスク アクティーゼルスカブ ヘテロ環化合物類の使用
WO1997001558A1 (en) * 1995-06-29 1997-01-16 Novo Nordisk A/S Novel substituted azabicyclic compounds
JPH11508540A (ja) * 1995-06-29 1999-07-27 ノボ ノルディスク アクティーゼルスカブ 新規の置換アザ環式またはアザ二環式化合物
AU7125096A (en) * 1995-09-22 1997-04-09 Novo Nordisk A/S Novel substituted azacyclic or azabicyclic compounds
JPH11512443A (ja) * 1995-09-22 1999-10-26 ノボ ノルディスク アクティーゼルスカブ 新規な置換アザ環式またはアザ二環式化合物
EP1236727A1 (de) * 2001-03-01 2002-09-04 Bayer CropScience GmbH Azabicycloverbindungen als Pestizide
MXPA04007936A (es) * 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB239309A (en) * 1924-06-18 1925-09-10 George William Hale Improvements in radiotelephonic and other radio-frequency signalling systems
GB261763A (en) * 1925-11-18 1927-09-08 British Thomson Houston Co Ltd Improvements in and relating to vapour electric devices
GB287356A (en) * 1927-06-02 1928-03-22 John Harris Improvements in or relating to mechanical ore roasting furnaces
GB307142A (en) * 1927-12-23 1929-03-07 Erik Schirm Improvements in or relating to organs, harmoniums and like musical instruments
GB307141A (en) * 1927-12-23 1929-03-07 British Dyestuffs Corp Ltd Improvements in detergent, cleansing and polishing compositions
GB316718A (en) * 1928-05-23 1929-08-08 Howden James & Co Ltd Improvements in or relating to air heaters
GB322182A (en) * 1928-05-24 1929-11-25 Tiefbau Und Kalteindustrie A G A process for the solidification of sandy masses permeable by water
GB323864A (en) * 1928-11-16 1930-01-16 Daniel Tyrer Improved process for obtaining a mixture of hydrogen and carbon monoxide by the decomposition of hydrocarbon gases or vapours in the presence of steam
GB339834A (en) * 1929-01-21 1930-12-18 Goodrich Co B F Improvements in or relating to methods of preserving rubber and to age-resisting rubber products produced thereby
GB366304A (en) * 1930-06-04 1932-02-04 Nicolaas Van Der Willik Moulded articles such as tiles, plates, floor-and wall-coverings and process for their manufacture
GB363085A (en) * 1930-11-11 1931-12-17 Edward Barker Improvements in conveyors
GB375450A (en) * 1931-04-01 1932-06-30 Robert Constantine Graseby Improvements in or relating to electric signalling systems and apparatus
GB402056A (en) * 1932-04-11 1933-11-13 Joseph Stephens Improvements in jet pumps and the like
GB398616A (en) * 1932-06-17 1933-09-21 Gen Electric Co Ltd Improvements in or relating to systems for the distribution of music, speech or the like over line wires
GB398617A (en) * 1932-06-21 1933-09-21 Gordon Fraser Improvements in or relating to sliver balling machines
EP0261763B1 (de) * 1986-06-27 1994-02-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen
ATE133415T1 (de) * 1987-04-15 1996-02-15 Beecham Group Plc Am brückenkopf substituierte azabicyclenderivate
EP0322182A3 (de) * 1987-12-22 1992-01-02 Beecham Group Plc Azabicyclische-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0363085A3 (de) * 1988-10-03 1991-03-27 Beecham Group Plc Chemische Verbindungen
EP0402056A3 (de) * 1989-06-06 1991-09-04 Beecham Group p.l.c. Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
EP0414394B1 (de) 1995-07-05
KR910004616A (ko) 1991-03-29
GB8917957D0 (en) 1989-09-20
JP2958655B2 (ja) 1999-10-06
AU6013090A (en) 1991-02-07
JPH03178976A (ja) 1991-08-02
ATE124697T1 (de) 1995-07-15
AU629668B2 (en) 1992-10-08
PT94910A (pt) 1991-04-18
DE69020661T2 (de) 1996-01-11
US5470859A (en) 1995-11-28
EP0414394A3 (en) 1991-05-08
DE69020661D1 (de) 1995-08-10
CA2022633A1 (en) 1991-02-06
EP0414394A2 (de) 1991-02-27
IE902818A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
ATE133415T1 (de) Am brückenkopf substituierte azabicyclenderivate
GB2262093B (en) Piperazine derivatives
EP0366304A3 (de) Heterocyclische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
GR3006247T3 (de)
EP0487502A3 (en) Pharmaceutically active aryl-substituted amine derivatives
AU629668B2 (en) Heterocyclic substituted azabicyclic compounds for pharmaceutical use
NZ232283A (en) Substituted imidazo(1,2-b)pyridazine derivatives; pharmaceutical compositions and preparatory processes
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
EP0413545A3 (en) Azabicyclic compounds
GR3007087T3 (de)
NZ225099A (en) Ergoline n-oxide derivatives and pharmaceutical compositions
DK210387A (da) Heterocykliske forbindelser og fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse